Author:
Preuss S F,Weinell A,Molitor M,Stenner M,Semrau R,Drebber U,Weissenborn S J,Speel E J M,Wittekindt C,Guntinas-Lichius O,Hoffmann T K,Eslick G D,Klussmann J P
Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. Altieri DC (2006) Targeted therapy by disabling crossroad signaling networks: the survivin paradigm. Mol Cancer Ther 3: 478–482
2. Balz V, Scheckenbach K, Gotte K, Bockmuhl U, Petersen I, Bier H (2003) Is the p53 inactivation frequency in squamous cell carcinomas of the head and neck underestimated? Analysis of p53 exons 2–11 and human papillomavirus 16/18 E6 transcripts in 123 unselected tumor specimens. Cancer Res Mar 6: 1188–1191
3. Borbely AA, Murvai M, Konya J, Beck Z, Gergely L, Li F, Veress G (2006) Effects of human papillomavirus type 16 oncoproteins on survivin gene expression. J Gen Virol 2: 287–294
4. Engels K, Knauer SK, Metzler D, Simf C, Struschka O, Bier C, Mann W, Kovacs AF, Stauber RH (2007) Dynamic intracellular survivin in oral squamous cell carcinoma: underlying molecular mechanism and potential as an early prognostic marker. J Pathol 5: 532–540
5. Freier K, Pungs S, Sticht C, Flechtenmacher C, Lichter P, Joos S, Hofele C (2007) High survivin expression is associated with favorable outcome in advanced primary oral squamous cell carcinoma after radiation therapy. Int J Cancer 4: 942–946
Cited by
50 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献